NCT01202175View on ClinicalTrials.gov

Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2013

Conditions
Pre-hypertensionHypertension
Interventions
DRUG

Nebivolol

Oral nebivolol 2.5-5mg once daily

Trial Locations (1)

92093

University of California, San Diego, La Jolla

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

University of California, San Diego

OTHER